Factors influencing the inhibitory action of anti-inflammatory drugs on carrageenin induced oedema.
D000284:Administration, Oral; D000818:Animals; D001241:Aspirin / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism; D002351:Carrageenan; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D006614:Hindlimb; D006813:Humidity; D007213:Indomethacin / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism; D007274:Injections, Intraperitoneal; D007408:Intestinal Absorption; D010653:Phenylbutazone / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism; D051381:Rats; D013696:Temperature
D002351:Carrageenan; D010653:Phenylbutazone; D001241:Aspirin; D007213:Indomethacin